Table 5.
Harrell’s C‐Statistics Reflecting Discriminative Ability of MRCP to Predict Progression to PSC‐Related Complication and Liver Transplant
| MRCP Score | C‐Statistic for PSC Complication (SE) | C‐Statistic for LT (SE) |
|---|---|---|
| IHD score | 0.73 (0.05) | 0.79 (0.06) |
| EHD score | 0.73 (0.10) | 0.93 (0.03) |
| Sum IHD‐EHD score | 0.80 (0.06) | 0.97 (0.01) |
| Average IHD score | 0.77 (0.06) | 0.77 (0.06) |
| Average EHD score | 0.68 (0.10) | 0.88 (0.07) |
| Sum average IHD‐EHD score | 0.75 (0.06) | 0.90 (0.03) |
| ALT (U/L) | 0.49 (0.09) | 0.32 (0.10) |
| AST (U/L) | 0.44 (0.10) | 0.75 (0.10) |
| ALP (U/L) | 0.65 (0.11) | 0.81 (0.09) |
| GGT (U/L) | 0.64 (0.10) | 0.80 (0.09) |
| Total bilirubin (µmol/L) | 0.83 (0.07) | 0.83 (0.14) |
| Albumin (g/L) | 0.62 (0.10) | 0.63 (0.11) |
| Platelets (109/L) | 0.65 (0.13) | 0.56 (0.20) |
| METAVIR fibrosis stage | 0.77 (0.08) | 0.71 (0.15) |
| PSC MRS | 0.75 (0.08) | 0.79 (0.12) |